Grail [GRAL] vs Thermo Fisher [TMO] Detailed Stock Comparison

Grail

NASDAQ
Loading...

Thermo Fisher

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Grail wins in 6 metrics, Thermo Fisher wins in 11 metrics, with 0 ties. Thermo Fisher appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricGrailThermo FisherBetter
P/E Ratio (TTM)-1.0331.46Grail
Price-to-Book Ratio1.024.06Grail
Debt-to-Equity Ratio2.6969.62Grail
PEG Ratio0.015.54Grail
EV/EBITDA-4.4021.64Grail
Profit Margin (TTM)-62.12%15.24%Thermo Fisher
Operating Margin (TTM)-368.15%17.84%Thermo Fisher
EBITDA Margin (TTM)N/A17.84%N/A
Return on Equity-17.68%13.42%Thermo Fisher
Return on Assets (TTM)-11.81%4.97%Thermo Fisher
Free Cash Flow (TTM)$-582.36M$7.27BThermo Fisher
Dividend YieldN/A0.31%N/A
1-Year Return402.99%-9.24%Grail
Price-to-Sales Ratio (TTM)17.604.75Thermo Fisher
Enterprise Value$1.79B$234.09BThermo Fisher
EV/Revenue Ratio13.355.42Thermo Fisher
Gross Profit Margin (TTM)-50.01%40.61%Thermo Fisher
Revenue per Share (TTM)$4$114Thermo Fisher
Earnings per Share (Diluted)$-11.71$17.27Thermo Fisher
Beta (Stock Volatility)N/A0.78N/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Grail vs Thermo Fisher Stock Performance Analysis

Loading Price Chart...

Grail
Thermo Fisher
Grail Stock Overview | Thermo Fisher Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Grail1.26%31.45%102.16%40.28%163.42%265.74%
Thermo Fisher3.50%17.03%12.13%26.55%15.59%3.97%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Grail402.99%348.29%348.29%348.29%348.29%348.29%
Thermo Fisher-9.24%3.76%16.92%329.43%1,044.80%1,683.13%

News Based Sentiment: Grail vs Thermo Fisher

Grail

News based Sentiment: POSITIVE

Despite a slight earnings miss, Grail experienced strong revenue growth, positive analyst upgrades, and increased institutional investment in October. The upcoming presentation of the PATHFINDER 2 study results represents a significant catalyst for the company's future, making this a noteworthy month for investors.

View Grail News Sentiment Analysis

Thermo Fisher

News based Sentiment: POSITIVE

Thermo Fisher Scientific demonstrated a strong month with strategic acquisitions (Solventum's purification business for $4.1 billion and Sanofi's sterile fill-finish site), innovative product launches, and positive financial results exceeding expectations in Q2 2025. This, combined with optimistic guidance, signals a positive trajectory for the company and strengthens the investment case.

View Thermo Fisher News Sentiment Analysis

Performance & Financial Health Analysis: Grail vs Thermo Fisher

MetricGRALTMO
Market Information
Market Cap i$2.36B$206.14B
Market Cap CategoryMid capMega cap
10 Day Avg. Volume i1,216,1933,290,780
90 Day Avg. Volume i879,3642,194,303
Last Close$65.54$543.32
52 Week Range$12.33 - $73.74$385.46 - $611.49
% from 52W High-11.11%-11.15%
All-Time High$73.74 (Oct 03, 2025)$672.34 (Dec 27, 2021)
% from All-Time High-11.12%-19.19%
Growth Metrics
Quarterly Revenue Growth0.11%0.03%
Quarterly Earnings Growth0.11%0.05%
Financial Health
Profit Margin (TTM) i-0.62%0.15%
Operating Margin (TTM) i-3.68%0.18%
Return on Equity (TTM) i-0.18%0.13%
Debt to Equity (MRQ) i2.6969.62
Cash & Liquidity
Book Value per Share (MRQ)$64.21$133.77
Cash per Share (MRQ)$16.72$16.92
Operating Cash Flow (TTM) i$-370,048,000$7.58B
Levered Free Cash Flow (TTM) i$-142,499,120$5.18B
Dividends
Last 12-Month Dividend Yield iN/A0.31%
Last 12-Month Dividend iN/A$1.21

Valuation & Enterprise Metrics Analysis: Grail vs Thermo Fisher

MetricGRALTMO
Price Ratios
P/E Ratio (TTM) i-1.0331.46
Forward P/E i-5.5823.13
PEG Ratio i0.015.54
Price to Sales (TTM) i17.604.75
Price to Book (MRQ) i1.024.06
Market Capitalization
Market Capitalization i$2.36B$206.14B
Enterprise Value i$1.79B$234.09B
Enterprise Value Metrics
Enterprise to Revenue i13.355.42
Enterprise to EBITDA i-4.4021.64
Risk & Other Metrics
Beta iN/A0.78
Book Value per Share (MRQ) i$64.21$133.77

Financial Statements Comparison: Grail vs Thermo Fisher

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)GRALTMO
Revenue/Sales i$31.84M$10.36B
Cost of Goods Sold i$51.77M$6.13B
Gross Profit i$-19.93M$4.24B
Research & Development i$53.63M$342.00M
Operating Income (EBIT) i$-153.61M$1.82B
EBITDA i$-114.33M$2.73B
Pre-Tax Income i$-146.41M$1.62B
Income Tax i$-40.20M$95.00M
Net Income (Profit) i$-106.21M$1.51B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)GRALTMO
Cash & Equivalents i$133.90M$4.13B
Total Current Assets i$727.66M$23.38B
Total Current Liabilities i$74.98M$13.17B
Long-Term Debt i$51.34M$31.37B
Total Shareholders Equity i$2.41B$49.49B
Retained Earnings i$-9.91B$54.45B
Property, Plant & Equipment i$126.94MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)GRALTMO
Operating Cash Flow i$-88.63M$2.15B
Capital Expenditures i$-62,000$-350.00M
Free Cash Flow i$-95.07M$361.00M
Debt Repayment iN/A$-838.00M
Common Stock Repurchase iN/A$-2.00B

Short Interest & Institutional Ownership Analysis

MetricGRALTMO
Shares Short i4.47M3.83M
Short Ratio i6.442.34
Short % of Float i0.14%0.01%
Average Daily Volume (10 Day) i1,216,1933,290,780
Average Daily Volume (90 Day) i879,3642,194,303
Shares Outstanding i33.89M380.77M
Float Shares i24.18M376.74M
% Held by Insiders i0.14%0.00%
% Held by Institutions i0.74%0.92%

Dividend Analysis & Yield Comparison: Grail vs Thermo Fisher

MetricGRALTMO
Last 12-Month Dividend iN/A$1.21
Last 12-Month Dividend Yield iN/A0.31%
3-Year Avg Annual Dividend iN/A$1.33
3-Year Avg Dividend Yield iN/A0.07%
3-Year Total Dividends iN/A$3.99
Ex-Dividend DateN/AMar 14, 2025